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Summary 
Six genomic clones were characterized containing members of the human V36 subfamily of T 
cell antigen receptor genes. There were four major findings. (a) New V3 genes were discovered, 
including V36.10,  V313.4,  V313.5,  and V35.5.  (b) Members of the V313,  V/~6,  and V35 
subfamilies cluster together in the V3 locus and may have evolved through multiple duplication 
events of an ancestral cassette containing V~13-V36-V35 genes. These V3 subfamilies are used 
by an estimated one-third ofT cells in humans and probably represent a highly useful component 
of the V3 repertoire. (c) The promoters ofV313, V36, and VB5 genes contain conserved decamer 
motifs, but discrete differences were observed between promoters of different V3 subfamilies, 
raising the question of different transcriptional control depending on V3 subfamily usage. (d) 
The new V36.10 gene is probably a pseudogene, which may have been inactivated due to retro- 
transposition of Alu elements into its promoter region, a mutation affecting a highly conserved 
cysteine residue or mutations of the 3' recombinase signal sequence. 
T 
he o#B TCR is responsible for recognition of the antigen/ 
MHC complex of APC and is expressed by m95% of 
human peripheral blood T cells. To create sufficient diversity 
for  recognition  of a  huge  number  of different antigenic 
specificities,  several mechanisms are used (1). First, two sets 
of genomic gene segments are available to each T  cell en- 
coding V3, D3, J3,  C3,  voe, Jcr, and Cot segments. The 
V gene loci contain approximately >50 Vc~ and ~>57 V3 gene 
segments (2-9).  Second, V-D-J gene rearrangement medi- 
ated by recombinase provides considerable combinatorial diver- 
sity. Third, junctions at which gene segments are joined are 
characterized by nucleotide loss and addition of nucleotides 
by terminal deoxy-transferase, thus creating what is termed 
"N-region" diversity. 
Because most TCR gene sequences are obtained from rear- 
ranged cDNA clones, very little is known about the germ- 
line structures of V gene segments. These are of particular 
interest because each V gene is preceded by its own individual 
promoter, which will control the expression of the mature, 
functionally rearranged, B chain (10-12).  In contrast, TCR 
cr and 3  enhancers are located 3' to the respective C regions 
(13-17) and can therefore be used by every T cell. Moreover, 
genomic sequences of V gene segments can provide useful 
information on the existence of possible pseudogenes, on in- 
trons, on signal sequences for recombinase, and on allelic forms 
of V genes. The latter question is of some importance, since 
allelic variations of V gene segments are apparently a common 
finding (18-21),  and could possibly be related to disease sus- 
ceptibility, although there are no conclusively established ex- 
amples yet (18). 
Materials and Methods 
Probes.  The following probes were used for screening  a genomic 
library, for restriction mapping, and for Southern blot analyses: 
(a) a 108-bp EcotLI/BstXI fragment derived from the cDNA clone 
OT-1 (20), designated OT-V, which represents the Y end of the 
V/~6.7a gene sequence; (b) probe Vph79 derived from the cDNA 
clone ph79 (4), containing 249 bp of V/36.7a 5' to the internal 
BamHI site of V/~6.7a (20); (c) an intron probe derived from clone 
GL-PA (20) containing a 149-bp HinflI fragment corresponding 
to the intron sequences of V/36.7b; (d) probe Vph5 derived from 
the cDNA clone ph5 (4), covering 276 bp of the coding sequence 
of V/36.3, from the ATG codon to the internal BamHI site; (e) 
two additional Vt5 probes derived from the cDNA clone pCEM-1 
(22) (V313.2) and from the clone p12A1 (23) (V/35.3), kindly 
provided by Drs. A. Duby and J. Leiden, respectively;  (J) the UAS-2 
clone, kindly provided by A. E. Hinkkanen andJ. T. Epplen (Max- 
Planck-Institute for Immunology, Frdburg, Germany), containing 
a rearranged V~6.7a gene segment (24). 
Southern Blotting.  Human genomic DNA was isolated from 
EBV-transformed  B lymphoblastoid  cell lines, digested with BamHI 
or other restriction enzymes, separated by 0.7% agarose gel dec- 
trophoresis, and then transferred to charge-modified  nylon-66 filters 
(Gelman Sciences, Inc., Ann Arbor).  After baking in a vacuum 
oven for 2 h, the blot was prewashed at 65~  0.1x  SSC in 0.5% 
SDS for 1 h, and prehybridized at 42~  in 5 x  SSPE, 5 x  Den- 
hardt's, 50% formamide, 100 #g/ml denatured salmon sperm DNA, 
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32p, using  a random  primer  extension labeling  kit (Boehringer 
Mannhdm Biochemicals, Indianapolis, IN). Hybridization was per- 
formed in the prehybridization buffer with labeled probes at 10' 
cpm/ml. After hybridization,  blots were washed twice with 2x 
SSC, 0.5% SDS for 20 min each, followed by two washes with 
0.1x  SSC, 0.5% SDS for 20 min each at 68~  The filters were 
then exposed to Kodak XAR.-5 film at -70~  with an intensifying 
screen. Blots were rehybridized, after removing the original signal, 
by incubating  the blot in the prehybridization buffer at 65~  for 
30 rain followed by prehybridization  at 42~  overnight. 
Screening of the Human Genomic Library.  A human genomic li- 
brary consisting of placental DNA, partially digested with Sau3A, 
and ligated into the BamHI site of ~,-EMBL3 (Clontech Laborato- 
ries, Inc., Palo Alto,  CA) was obtained.  The titer of the library 
was  3  x  109/ml. Approximately  107 phage  were  screened on 
150-ram plates at a density of 5  x  10. plaques per plate. Repli- 
cate nitrocellulose filters (Schleicher & Schuell, Inc., Keene, NH) 
were baked under vacuum at 80~  for 2 h, prewashed with 0.1x 
SSC, 0.5% SDS at 65~  for 30 min, prehybridized with 5 x SSPE, 
5 x Denhart's, 50% formamide, 100/~g/ml denatured salmon sperm 
DNA, 0.1% SDS at 42~  for 6 h, then hybridized overnight with 
3zp-labeled V/~ probes (at 5  x  105 to 1 x  106 cpm/ml).  The filters 
were washed first at room temperature  with 2x  SSC, 0.5%  of 
SDS, and then twice at 65~  followed by two washes in 0.1x 
SSC 0.5% SDS at 65~  for 20 rain each. After washing, filters 
were dried and exposed to Kodak XAIL-5 film at  -70~  with 
an intensifying screen. After the first round of screening, positive 
phages were selected and soaked out of the agar gel plugs into SM 
buffer (100 mM NaC1, 80 mM MgSO~, 50 mM Tris-C1, pH 7.5). 
These phages were further purified until homogeneous.  ~, DNA 
was prepared from the positive clones by liquid culture  and the 
cesium chloride banding  method (25). 
Subcloning and Restn'ction Mapping of Genomic Clones.  Purified 
~, DNA samples from positive clones were digested first by SalI 
and run on a 0.6% agarose gel. The average length of inserts in 
VB6-positive clones was '~15 kb. Each insert was subdoned into 
the SalI site of a plasmid vector PIBI31. After transformation  into 
the host bacteria DH5c~, the phsmid DNA was isolated from 25-50 
ml bacterial culture  suspension by the boiling  method (25). For 
restriction mapping, the enzymes BamHI, EcoRI, KpnI, and Sad 
were used in single or double digestion reactions. The restriction 
maps were constructed  and confirmed by Southern blot analysis 
using  the probes as described above. 
The transcriptional  orientations  of the V/~ genes were deter- 
mined by Southern blotting and sequences analysis. For instance, 
specific probes corresponding to the 5' and 3' portions of VB6.7a 
or V/~13.2 were used to delineate the location and orientation  of 
the V/~6.7a and VB13.2 gene segments in done 5-2. In clone 11, 
a 3.9-kb KPOI fragment spans the V~6.10 and VB13.3 genes. By 
subdoning and sequendng this fragment the orientation  of both 
genes could be determined. The same strategy was used for V/~6.1 
and V/~5.5 in clone 9. For clone 4-1, a PvuII site located in the 
coding region of Vfl13.4 (not shown) was used to determine the 
orientation  of V~13.4. 
Sequencing.  Relevant restriction fragments were subeloned into 
PIBI31. The plasmid DNA was isolated from transformed DHS~x 
and the sequence determined by the dideoxy chain termination se- 
quencing method of Sanger et al. (26), using the universal T3 and 
T7  primers, as well  as  specifically synthesized  oligonucleotide 
primers. Both strands were completely sequenced. The computer 
program  used to align sequences and compute homologies was 
"genalign" using the "clustered pair-wise region method" (27). Pro- 
motet sequences were analyzed by D. Ghosh (National Center for 
Biotechnology Information,  NIH, Bethesda, ME)) with "SITES, 
table of release 3.0 of TFD" (28). The identical match (IM) proba- 
bility is the probability that the SITES data base sequence would 
match with 100% identity somewhere in a random sequence with 
equivalent length to the sequence being analyzed. 
Results 
Genomic Organization of V~6 Genes.  Six genomic clones 
were isolated from a human  placental DNA library using 
VB6.7a and VB6.3 cDNA probes. The restriction enzyme 
maps of these dones are shown in Fig.  1. From these data 
it is clear that  three clones (clones 9,  3, and 13) represent 
overlapping clones of the same locus. All three dories con- 
tain the V/~6.1 gene, which was confirmed by sequence anal- 
ysis of subdoned coding and flanking regions. Moreover, the 
VB6.1 gene is adjacent to two new VB genes, termed V~13.5 
and VBS.5, which were found '~3 kb upstream and "~4 kb 
downstream, respectively (Fig. 1). The other three genomic 
clones each represent a separate locus: clone 4-1 contains the 
V~6.3 gene, clone 5-2 contains the VB6.7a gene, and clone 
11 contains a new VB gene, termed VB6.10. Each of these 
V/~6 genes is associated with a VB13 gene located at variable 
distances upstream. Two of these VB13 genes are newly de- 
scribed genes, termed V#13.3 and 13.4. Analysis of large re- 
striction enzyme fragments by pulsed field gel electropho- 
resis,  analysis  of deletion variants of the TCR ~  locus, and 
analysis of cosmid clones have indicated that VB13, VB6, and 
V~5 genes are often found in close proximity to each other 
(29). Fig. I demonstrates that members of these three subfa- 
milies are probably contained within a cassette with a con- 
served order of V genes (5' VB13-V~6-V~5 3'). At all four 
loci, VB6 genes are preceded by an upstream V313 gene. Our 
data are consistent with those ofLai et al. (29), and the com- 
bined data suggest that multiple duplication events of such 
a cassette characterize the evolution of the TCR 3 locus. Clones 
4-1, 5-2, and 11 (Fig. 1) lack a V~5 gene by Southern blot- 
ting (with a VB5.3 and a VflS.5 probe) and by PCR with 
primers  common  to  all  known VB5 sequences.  However, 
clones 4-1 and 5-2 may not extend far enough downstream 
to include a putative V35 gene. It is therefore not possible 
to absolutely exclude a V35 gene associated with these loci. 
Moreover, the cassette alluded to above may not necessarily 
be complete in every instance. This would explain the vari- 
able total number of V  genes in each of these subfamilies, 
estimated at five Vf113 genes, 8-10 Vfl6 genes, and five V35 
genes (8). 
Nucleotide Sequences of Vl~6, V~13, and V~5 Genes.  V36 
is the largest human V~/subfamily. At least 12 different se- 
quences are known (2, 20) (Li, Y., and D. Posnett, unpub- 
lished data). Differences between some sequences are minor. 
For instance,  there is only one silent nucleotide difference 
between the coding regions of VB6.6 and V/~6.7a (2). Such 
minor differences may represent allelic forms of the same gene 
rather than two different genes. Two allelic forms of VB6.7 
(V/~6.7a  and VB6.7b) have been described in detail and en- 
code expressed B chains that differ at two amino acid posi- 
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Figure  1.  Restriction  enzyme 
map of six genomic clones hybrid- 
izing with a VB6.7a probe. Clones 
9, 3, and 13 are overlapping at the 
V~13.5-V~6.1-V~5.5  locus.  The 
boxes represent the e~ons of the V 
genes (their size is enlarged and out 
of scale for clarity). B, BamHI, K, 
KpnI, E, EcoRI. 
Figure 2.  Genomic sequences of V36 genes. The clones are described in Fig. 1. UAS2 (24) and V36.7b (20) were used for comparison. The former 
is a rearranged clone and the htter was obtained by PCR amplification from genomic DNA. Sequences corresponding  to leader, intron, GT repeats, 
V region,  and 3' hepatamer and nonamer (shaded) are indicated. Spaces were introduced  in the introns to optimize alignment, and on either side of 
the intron for clarity. Capital  letters indicate sequence identity with aligned residues above or below. 
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aUdes of VB6.7. The V136.7 gene contained in done 5-2 has 
an identical coding region sequence to the prototypic UAS2 
(VB6.7a)  sequence, but differs in the intron (Fig.  2). Both 
sequences are also identical over *200 bp of promoter se- 
quence upstream of the ATG codon (see Fig. 8). Thus, the 
sole difference between the two sequences is the number of 
GT  repeats  found  in  the  intron:  (GT)21 for  UAS2  and 
(GT)z4 for the VB6.7a gene of done 5-2.  Previous analysis 
of (GT)n repeats has shown that these sequences can be very 
polymorphic (30, 31). Since the two aUdes do not differ in 
peptide sequence, we have opted not to distinguish the new 
5-2-derived  sequence by a lower case letter and consider it 
another allele encoding the V/36.7a peptide sequence. 
The genomic sequences shown in Figs. 2-4 demonstrate 
that the VB6, VB13, and VB5 genes have a similar structure. 
The first exon encodes NH2-terminal leader peptide residues 
and the second exon encodes the rest of the leader and the 
V segment sequences. The introns reveal the most conspic- 
uous differences between these three V gene subfamilies. V136 
subfamily members all contain (GT)n repeats in the intron, 
while these repeats  are lacking in the VB13 and the VB5.5 
genes.  In each case, the (GT)n sequence appears at almost 
the same position in the intron, beginning at position 28-31 
Figure  4.  Genomic sequences of the V~5.5 gene.  This sequence was obtained from clone 9 (Fig.  1) and is compared to cDNA sequences from 
the literature: V~5.1,  clone HBP51  (2,  7); V~35.2, clone PL2.5  (6);  V/35.3,  clone 12A1 (58); V/35.4,  clone Ph24  (4).  See also legend to Fig. 2. 
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sequences shown in Fig. 2, the (GT)n repeat differs each time 
by a multiple of two nudeotides (n  =  24 for V/~6.7a from 
5-2; n  =  21 for Vfl6.7a from UAS2; n  --  15 for V/36.7b). 
Similar simple repeats capable of assuming non-B secondary 
DNA configurations are observed in the introns of several 
human and murine TCK V gene segments (18). Such mini- 
satellite repeat sequences may serve to promote recombina- 
tion events such as homologous recombination and gene con- 
version. Alternatively, they may serve as enhancer elements 
and play a role in gene expression  (32-35), but their exact 
function remains unknown. 
The 3' flanking sequences of V~6, VB13, and V~5.5 gene 
segments contain the conserved heptamer and nonamer signal 
sequences for recombinase-mediated VDJ recombination sepa- 
rated by 23 bp of nonconserved sequence (Figs. 2-4) (36). 
However, the nonamer sequence was absent in V/~6.10 (Fig. 
2), while the heptamer was found at the expected position. 
These data suggest that the V~6.10 gene may not be able 
to recombine into a functional ~  chain gene. 
The V~5.5 gene (Fig. 4) represents the sole example of 
a genomic sequence from this VB subfamily. The intron begins 
with an AT rather than the more usual GT dinucleotide. How- 
ever, the intron ends with the typical AG sequence. 
All V/3 sequences from the genomic clones were compared 
for homology  by considering exon sequences, intron sequences, 
and promoter sequences (see Fig. 8) separately. Homology 
matrices expressed in percentages are shown in Table 1. Overall, 
homology is highest in the coding region. Homologies were 
lower among the intron sequences and the promoter sequences. 
As expected, homologies  were greatest within a Vfl subfamily. 
The new VB6.10 gene is most closely related to Vfl6.7a. The 
Table  1.  Scoring Matrices for Exon, Intron, and Promoter Sequences 
Vb6.1  Vb6.7a  Vbuas2  Vb6.10  Vb6.3  Vb5.5  Vb13.2  Vb13.3  Vb13.4  Vb13.5 
1  2  3  4  5  6  7  8  9  10 
A.  Exon  1  89.3  89.5  85.6  81.0  46.4  43.6  45.1  42.2  43.6 
2  100.0  88.5  83.9  46.1  45.6  47.1  44.2  45.3 
3  88.5  83.9  46.1  45.6  47.1  44.2  45.3 
4  81.8  44.9  44.2  45.1  41.6  43.3 
5  53.1  45.3  46.2  44.8  44.8 
6  52.0  52.5  49.9  49.1 
7  91.0  89.8  79.4 
8  90.4  80.5 
9  80.8 
1  2  3  4  5  6  7  8  9  10 
B.  Intron  1  58.2  62.7  32.7  50.9  31.8  35.2  30.2  26.5  32.6 
2  96.1  42.9  47.4  28.2  33.0  33.7  31.3  30.3 
3  42.9  46.7  31.5  29.5  30.2  28.9  32.6 
4  29.2  25.0  27.3  29.1  30.1  32.6 
5  36.3  30.7  30.3  34.9  32.6 
6  34.1  25.6  28.9  24.7 
7  76.7  65.1  33.0 
8  69.9  69.8 
9  42.2 
1  2  3  4  5  6  7  8  9  10 
C.  Promoter  1  69.5  69.5  79.7  62.7  25.8  31.4  33.9  30.1  26.7 
2  100.0  64.0  61.0  20.8  25.1  28.8  30.1  27.5 
3  64.0  61.0  20.8  25.1  28.8  30.1  27.5 
4  57.6  25.8  28.7  31.8  29.7  29.7 
5  25.0  24.6  19.5  26.7  24.6 
6  23.1  22.9  24.2  23.7 
7  79.1  60.7  60.2 
8  59.5  58.9 
9  64.0 
1541  Li et al. Figure  6.  V~13 protein sequences. Sequences are derived from the genomic clones in Fig. 1 except for V/~13.1 (22). See legend of Fig. 5 for symbols. 
VB13 genes examined are closely related to one another, with 
the exception of VB13.5, which shows least homology with 
the other V~13 members (Table 1). 
Translated  Sequences of V~6, VB13,  and V~5 Genes.  In Figs. 
5-7,  the peptide sequences of the V genes encoded by our 
genomic clones are aligned with some reference sequences 
from the same V~ subfamilies. The location of the CDR1 
and CDR2 loops is based upon comparisons of V gene se- 
quences with Ig V gene sequences and modeling of the TCR 
structure on the known Ig three-dimensional structure (37, 
38). CDR.1 and CDR2 are thought to interact with MHC 
antigen-presenting  molecules (1). V~6 peptides are one amino 
acid longer than V~/13 and V~5 peptides as described previ- 
ously (37, 38). This is probably due to differences in the size 
of the CDR2 loop. Amino acid residues that are highly con- 
served and contribute to the Ig domain structure (37,  38) 
are indicated by an asterisk in Figs.  5-7,  and residues  that 
define V~ subgroups (8, 37, 38) are identified by the pound 
sign. All these residues  are conserved within the new VB 
sequences reported herein. There is one significant exception 
in the VB6.10 gene sequence where C 23 is replaced by y23. 
Thus, the disulfide bond between C 23 and C 92, which is es- 
sential for an Ig domain structure, cannot be formed by the 
VB6.10 gene product. 
Peptide homology matrices (Figs. 5-7) indicate that within 
the V/~6 subfamily, V~6.1, V~6.7a, and VB6.10 are closely 
related to one another. VB6.5 and V~6.8 represent a different 
example of closely related VB6 genes. V~6.3 is least homol- 
ogous with the tested sequences. Within the V~13 subfamily, 
V~13.1 and VB13.4 are most homologous, while V~13.2 
Figure  7.  V35 protein sequences. The V~5.5 sequence is from done 9 (Fig. 1). Other sequences are as described in Fig. 4. See legend of Fig. 5 for symbols. 
1542  Structure of Human VB6 T  Cell Antigen Receptor Genes Figure  8.  V13 promoter sequences. Promoter areas were sequenced from the clones shown in Fig.  1. The promoter of the rearranged  clone UAS2 
(VB6.7a) was also sequenced. Sequences are arranged by V gene subfamily and dots indicate sequence identity with the top sequence of the respective 
subfamily. Within a V gene subfamily, the entire promoter region is conserved. The locations of the consensus decamer and a TRE motif in the V/35.5 
promoter are indicated, as are possible locations of TATA sequences. The site of the transposon insertion within the VB6.10 promoter sequence (sequence 
no. 3) is indicated by two arrows. There are two variants of the VB13.5 promoter,  which differ at marked residues (*). One is represented by genomic 
clones 3 and 9 and contains G at  - 268 and C at  - 53. The other is represented by clone 13 and contains A at  - 268 and G at  - 53. Thus, the genomic 
clones  3,  9,  and  13 may represent  different  alleles. 
and V1313.3 are more similar to one another. V1313.5 has least 
homology with the other VB13 sequences. Within the VB5 
subfamily, VBS.2 and V135.3 are closely related, as are VB5.1 
and V/35.4. The new gene, V/35.5, is similarly related to both 
of these subgroups of V{3 genes (Fig.  8). 
Promoter  Sequences.  Fig. 8 shows the 5' flanking sequences 
for the V~ genes described in Fig. 1. Approximately 200 bp 
of 5' flanking sequence obtained in our laboratory from the 
clone UAS2 (VlJ6.7a) are also included for comparison. Pro- 
moter sequences were analyzed with the SITES program de- 
scribed by Ghosh (28). A previously described TCR decamer 
motif  and a TRE-like motif  were observed (Fig. 8) with iden- 
tical match probabilities ranging between 1.74 and 7.04  x 
10-3. The conserved decanudeotide consensus sequence,  5' 
AGTGATGTCA 3; was found at variable positions (-80 to 
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-106)  in reference to the ATG codon. A  similar decamer 
was observed in the 5' flanking region of the human VB8.1 
and several murine V~ genes (12). This decamer sequence 
displays a degree of dyad symmetry  reminiscent of the common 
features of other regulatory factor binding sites. Usually these 
begin with TGA and end with TCA. The numbers of nucleo- 
tides inserted between TGA and TCA are variable. For ex- 
ample, TGACTCA has been identified as a TRE-like motif, 
and may represent the binding site for Ap-1 (39).  Another 
example is TGACGTCA, a palindromic sequence that has 
been associated with the cAMP response element (40,  41). 
Both motifs can be recognized by members of the fos/jun 
family (42). The decamers in Fig. 8 show a two-nudeotide 
insertion mode, NNTGATGTCA in the Vfl6 gene subfamily, 
and NNTGACATCA in the V~5.5 gene segment. An addi- :  /  5'  GAGTTTGAGACC  3' 
~pol  III  target  sequence 
5 '  ....  CATTGATGTTGTTAA~  GC~CTCATAAATATTTAA...  ATG  V~6.10 
.... CATTAACGTTGTTTACAAGGA  GCTTATAAATATTTAA...  ATG  V~6.7a 
....  CATTGATGTTGTTTAAAAGGA  GCTAATAAATATCTAA...ATG  V~6.1 
....  CATTGATAGTGGT~  GeTGA~AC~X~T~...~  V~.3 
Figure  9.  Transposon in the VB6.10  promoter.  The flanking direct 
repeats are shaded. The 3' Alu sequence represents a sense sequence, while 
the 5' Alu element is a reverse complement sequence. Both are homolo- 
gous to consensus Alu sequences. 
tional TILE-like motif is present in the VB5.5 promoter with 
a single nudeotide insertion sequence, TGAATCA. In con- 
trast,  a novel four-nucleotide insertion decamer sequence, 
TGAAGTCTCA or TGAGGTCTCA, was found in all V~13 
genes.  Extensive homology surrounding these consensus 
decamer sequences was observed.  Each decamer is preceded 
by a purine-rich sequence 10-20 bp long. DNAse footprint 
analysis in the promoter region of human VBS.1 (11) indi- 
cated that one of the protected areas contains the decamer 
motif, suggesting that this conserved motif represents a pro- 
tein binding site. 
A typical transposon-like insertion element was found in 
the 5' flanking region of the VB6.10 gene segment (Fig, 9). 
This is a 549-bp insertion at position -193 (Figs. 8 and 9). 
Homology between V~6.10 and VB6.1 is maintained (at 84% 
over 200 bp) both upstream and downstream of this inser- 
tion. The features of this insertion element include the fol- 
lowing. A 5-bp direct repeat (AAGGA) flanks the insertion 
on either side. The entire insertion is characterized  by two 
imperfect inverted repeats. The stem origin of the insertion 
contains a 5' run of poly(T)ls and a 3' run of poly(A)ls in- 
terrupted by some nudeotides (Fig. 9). Finally, the insertion 
element contains two Alu sequences head to tail. Although 
unusual, similar head-to-tail Alu sequences have previously 
been described (43). The 3' Alu sequence contains a perfect 
pollII target sequence, 5' GAGTTTGAGACC Y, in its shorter 
(L-handed) monomer unit (Fig. 9). Thus, this insertion ele- 
ment contains all the characteristics of Alu sequences (44, 45). 
Discussion 
Six genomic clones are described,  each containing a V/36 
gene segment. Several findings were made with these clones. 
(a) Several new human VB genes were discovered, including 
VB6.10,  VB13.4, VB13.5,  and VBS.5.  (b) Members of the 
VB6, VB13, and VB5 subfamilies duster together in the VB 
locus. These three subfamilies probably evolved by repeated 
duplications of a cassette containing V/~13-VB6-VB5 genes. 
(c) The promoter regions of all the genes belonging to these 
three subfamilies contain conserved motifs, such as the decamer 
motif, probably representing binding sites for trans-acting regu- 
lators. The promoter regions were conserved within subfam- 
ilies but less so between subfamilies.  (d) The VB6.10 gene 
is most likely a pseudogene, since it lacks a conserved recom- 
binase signal sequence, it contains a mutation of the highly 
conserved Cys  23 necessary for formation of an Ig-like do- 
main, and it contains a 549-bp  insertion of Alu sequences 
in its promoter, which may interfere with promoter activity. 
In a recent reevaluation  of the total number of VB gene 
segments (8), minimal estimates were made of five VB5 genes, 
eight V~6 genes, and five V~13 genes. These estimates are 
based on counting bands on Southern blots, which is un- 
reliable because the results depend strongly on the probe used. 
These estimates were also based on counts of genes on avail- 
able cosmid clones (29), but they remain minimal estimates, 
since the entire VB locus has not been characterized.  With 
this caveat in mind, it seems never the less likely that the 
newly described V~55.5 gene represents the last member of 
the VB5  subfamily.  The V~5.5 peptide sequence  is only 
70.7-76.1%  homologous to other V~5 sequences (Fig. 7). 
It is thus unlikely that it represents an allelic form of a previ- 
ously described VB5 sequence, in particular since these have 
each been cloned from different sources and the sequences 
are usually identical for each V~5 gene (2,3). 
The same argument applies to the V~13.3, V~13.4, and 
V~13.5 genes (Fig. 6). Moreover, these gene products, which 
are 68.1-88.5% homologous to the previously known V~13.1 
and V~13.2 gene products, are dearly derived from distinct 
genes at different loci (Fig.  1). Thus, the VB13 subfamily 
now contains five known members as previously predicted 
(8). A recent publication describes a PCR-derived V~13 cDNA 
clone called IGRb14,  which is  100%  homologous to our 
V~13.3 coding sequence (9). It is still unclear whether other 
new sequences described in this paper represent new loci or 
allelic variants  of known V~ genes. 
VB6 is the largest  human V~ subfamily. There are >10 
previously published sequences, of which two are definitely 
allelic forms of the same gene and are named V~6.7a and 
V~6.7b (20).  The VB6.6 sequence differs only by a single 
silent nucleotide change in the coding region from the VB6.7a 
sequence and probably represents another allele, although this 
has  not been formally proven. Also,  shown herein is the 
sequence of VB6.7a derived from the clone UAS2. This se- 
quence differs from the 5-2-derived  V~6.7a nucleotide se- 
quence in the intron, where the former contains a (GT)~.I 
repeat and the latter a (GT)z~ repeat.  All coding sequences 
and promoter sequences are alike. Thus, we chose to refer 
to both clones as encoding V~6.7a genes. These data imply 
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introns will be characterized by numerous allelic forms (18, 
30, 31). The majority of these alleles will be distinguished 
only by the number of dinucleotide repeat units. Occasion- 
ally, other mutations will be associated with a given allele, 
and a fraction of these will result in different peptides, as 
is the case for VB6.Ta and VB6.7b (20), but not for V~6.6. 
The availability of genomic clones of VB6.7, such as clone 
5-2, will facilitate a more extensive analysis of the allelic poly- 
morphisms associated with this gene. It will be of interest 
to compare this polymorphism with that of the adjacent up- 
stream gene, V/J13.2,  since V~6 introns all contain (GT)n 
repeats and V~13 introns do not. 
The new VB6 gene, V/~6.10, has greatest homology with 
V/~6.7a and VB6.1 (Table 1). Yet, all three sequences repre- 
sent separate genes (Fig. 1). V~6.10 is probably a pseudogene. 
The conserved nonamer in the 3' UT region, which is con- 
sidered a recombinase signal sequence, is missing. Since V/~6.10 
has not been isolated from cDNA libraries, it is probable that 
this V gene cannot undergo V-D-J recombination. Moreover, 
the highly conserved Cys  z3 residue,  which is necessary for 
formation of an Ig-like domain and forms a disulfide bond 
with Cys  92, is changed to a Tyr  23 in V~6.10.  Thus, it is 
questionable whether a VB6.10-encoded ~ chain could fold 
into an Ig-like domain. Lastly, the VB6.10 promoter con- 
tains a 549-bp insertion element at position -193 (Fig. 9) 
consisting of two head-to-tail Alu sequences. Such sequences 
are classified as nonviral retroposons and are thought to de- 
rive from processed 7SL RNA (44-46). These elements are 
transcribed by RNA polymerase III initiating at the 5' end 
of the left unit and transcribing through the 3'  terminal 
poly(A) tract. Reverse transcription is then primed on the 
poly(A) tract, providing a mechanism for retrotransposition 
(44,  45). 
Little is known about the significance of mobile genetic 
elements in humans, and Alu sequences in particular,  which 
frequently insert in introns or flanking sequences of genes, 
but generally not in exons. In certain cases, retrotransposons 
may have acted as insertional mutagens, resulting in inactiva- 
tion (47) or activation (48) of a cellular gene. In fact, retro- 
transposition has been directly demonstrated in human lung 
carcinoma cells transfected with a target gene. These cells 
were screened for insertion mutations, resulting in inactiva- 
tion of the gene. A  newly transposed Alu sequence was 
identified by these means (49). In other instances, retrotran- 
sposons have inactivated genes relevant to human disease, such 
as the factor VIII gene in hemophilia A  (50) or the c-myc 
gene in breast carcinoma cells (51). Retrotransposons have 
been associated with a high percentage of murine actin pseu- 
dogenes (52) and with homologous  recombination in humans 
(53).  The Alu sequences inserted in the V~6.10 promoter 
may have resulted in inactivation of this gene by interference 
with promoter function. The resultant V~6.10 pseudogene 
would then have undergone further mutation for lack of selec- 
tive evolutionary pressures. It remains possible that the in- 
serted Alu sequences upstream of VB6.10 are not present in 
all haplotypes and that V~6.10 may be a functional gene in 
some individuals. 
The significance of a genomic cassette containing members 
of the  VB13-V~6-vB5  subfamilies  remains  hypothetical. 
Clearly, these three V~ subfamilies represent the largest V~ 
subfamilies and together account for at least 18 V~ genes, 
i.e.,  "~32%  of the V~/repertoire assuming a total of ,,~57 
VB genes (8). One may estimate the usage of certain V~ genes 
with mAbs specific for VB gene products. Thus, the mean 
frequencies of VB usage are 3.2% for VB5.1/5.4, 2.8% for 
VB5.2/5.3, and 4.5% for VB6.7 (54-56,  and our unpub- 
lished results). Moreover, V~13 gene usage has been estimated 
by quantitative PCR at 9.0% for V~13.1, 2.7% for V/~13.2, 
and 7.8% for V~6.1-3. Thus, a minimal estimate of expres- 
sion of V~/13, V~6, and VIi5 genes is 30%, and these data 
are incomplete because of the absence of data for several genes 
in these three subfamilies. Therefore, we would propose that 
the V~ genes encoded by the three V~ subfamilies represent 
particularly useful VB genes to humans, and probably arose 
through multiple gene duplications of the basic  cassette 
structure. 
Lastly, the promoter sequences shown herein demonstrate 
strong conservation within a Vfl subfamily, but not between 
subfamilies  (Table 1 C). Moreover,  the consensus decanter 
discussed above demonstrates some discrete differences in lo- 
cation and sequence between Vfl subfamilies. Thus, one could 
postulate that control of transcription may differ in T cells 
depending on what Vfl subfamily is used. This could have 
relevance to observed differences of Vfl usage at different de- 
velopmental stages of T  cells (57). 
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X61447 (TCIL V1313.4); X61653 (TCR V/313.5). 
1545  Li et al. References 
1.  Davis, M.M., and P.J. Bjorkman. 1988. T-cell  antigen receptor 
genes and T-cell recognition.  Nature (Lond.). 334:395. 
2.  Toyonaga, B., and T.W. Mak.  1987. Genes of the T cell an- 
tigen receptor in normal and malignant  T cells. Annu. Rev. 
Imraunol. 5:585. 
3.  Wilson,  R.K., E. Lai, P. Concannon,  R.K. Barth, and L.E. 
Hood. 1988. Structure, organization and polymorphism of  mu- 
fine and human T cell receptor alpha and beta chain gene fam- 
ilies. Immunol. Rev. 101:149. 
4.  Tillinghast, J.P., M.A. Behlke and D.Y. 1,oh. 1986. Structure 
and diversity of the human T cell receptor/5 chain variable 
region genes. Science (Wash. DC).  233:879. 
5.  Kimura,  N., 13. Toyonaga, Y. Yoshikai, R-P. Du, and T.W. 
Mak.  1987. Sequences and repertoire of the human  T  call 
receptor cr and/5 chain variable region genes in thymocytes. 
Fur. J. Imraunol. 17:375. 
6.  Concannon, p., L.A. Pickering, P. Kung, and L. Hood. 1986. 
Diversity and structure of human T cell receptor/5 chain vari- 
able region genes. Proc. Natl.  Acad. Sci. USA.  83:6598. 
7.  Kimura, N., B. Yoyonaga,  Y. Yoshikai, M.D. Minden, and 'EW. 
Mak. 1986. Sequence and diversity of human T cell receptor 
/5 chain genes. J. Ext~ Med. 164:739. 
8.  Robinson, M.A. 1991. The human T cell receptor/5 chain gene 
complex  contains  at  least 57  variable gene  segments: 
identification of six VB genes in four new gene families.  J. 
Immunol.  146:4392. 
9.  Ferradini, L., S. Roman-Roman, J. Azocar, H. Michalaki, F. 
Triebel, and T. Hercend.  1991. Studies on the human T cell 
receptor o~//5 variable region genes. II. Identification of four 
additional V/5 subfamilies. Eur. J. Immunol. 21:935. 
10.  Siu, G., E.C. Strauss, E. Lai, and L.E. Hood. 1986. Analysis 
of a human  V/5 gene subfamily.  J. Ex? Med. 164:1600. 
11.  Royer, H.D., and E.L. Reinherz. 1987. Multiple nuclear pro- 
teins bind upstream sequences in the promoter region of a T 
cell receptor B chain variable region gene: evidence for tissue 
specificity. Proc. Natl. Acad. Sci. USA.  84:232. 
12.  Anderson, S.J., H.S. Chou, and D.Y. Loh. 1988. A conserved 
sequence in the T-cell  receptor/5-chain promoter region. Proc. 
Natl. AcacI. Sci. USA.  85:3551. 
13.  Winoto, A., and D. Baltimore. 1989. A novel inducible and 
T cell specific  enhancer  located at the 3' end of  the T cell receptor 
ol locus. EMBO (Eur. Mol. Biol. Organ.)  J. 8:729. 
14.  Krimpenfort, P., R. deJong, Y. Uematsu, Z. Dembic, S. Ryser, 
H. yon Boehmer, M. Steinmetz, and A. Berns. 1988. Tran- 
scription of T cell receptor/5 chain genes is controlled by a 
downstream regulatory element. EMBO (Eur. Mol. Biol. Organ.) 
j.  7:745. 
15.  Ho, I-C., L-H. Yang, G. Mode, and J.M. Leiden. 1989. A T 
cell specific transcriptional enhancer element 3' of Cc~ in the 
human  T  cell receptor cr  locus. Pro~ Natl. Acad. Sci. USA. 
86:6714. 
16.  Gottschatk,  L.R., and J.M. Leiden. 1990. Identification and 
functional characterization of  the human T cell receptor/5 gene 
transcriptional  enhancer: common nuclear proteins interact 
with  the transcriptional  regulatory  elements of the T  cell 
receptor cr  and/5 genes. Mol. Cell. Biol. 10:5486. 
17.  Redondo, J.M., S. Hata, C. Brocklehurst, and M.S. Krangel. 
1990. A T  cell specific transcriptional enhancer within the 
human T cell receptor c~ locus. Science (Wash. DC). 247:1225. 
18.  Posnett, D.N. 1990. Allelic variations of human TCR V gene 
products. Immunol.  Today. 11:368. 
19.  Robinson, M.A. 1989. Allelic sequence  variations in the hyper- 
variable region of a TCR/5 chain: correlation with restriction 
length polymorphism in human families and populations. Proc. 
Natl. Acad. Sci. USA.  86:9422. 
20.  Li, Y., P. Szabo, M.A. Robinson, B. Dong, and D.N. Posnett. 
1990. Allelic variations in the human T cell receptor V/56.7 
gene products. J. ExI~ Med. 171:221. 
21.  Pullen, A.M., W. Potts, E.K. Wakeland, J. Kappler, and P.M. 
Marrack. 1990. Surprisingly uneven distribution of the T cell 
receptor V/5 repertoire in wild mice. J. Ext~ Med. 171:49. 
22.  Duby, A.D., and J.G. Seidman. 1986. Abnormal recombina- 
tion products result from aberrant DNA rearrangement of  the 
human T cell antigen receptor beta-chain gene. Pwc Natl. Acad. 
Sci. USA.  83:4890. 
23.  Leiden,  J.M., D.P. Dialynas, A.D. Dub),, C. Murre, J. Seidman, 
and J.L. Strominger. 1986. Rearrangement and expression of 
T cell antigen receptor genes in human T lymphocyte tumor 
lines and normal human T cell clones: evidence for allelic ex- 
clusion of Ti/5 gene expression and preferential use of a J/32 
gene segment. Mol. Cell. Biol. 6:3207. 
24.  Hinkkanen,  A.E., V. Steimle, M. Schlesier, H.H. Peter, and 
J,T. Epplen. 1989. The antigen receptor of an autoreactive  T-cell 
clone from human rheumatic synovia. Imraunogenetics. 29:131. 
25.  Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular 
Cloning: A Laboratory Manual. Cold Spring Harbor Labora- 
tory, Cold Spring Harbor,  NY. 
26.  Sanger, F., S. Nicklen,  and A.R. Coulson.  1977. DNA se- 
quencing with chain-terminating inhibitors. Pro~ Natl. Acad. 
Sci. USA.  74:5463. 
27.  Sobel,  E., and H.M. Martinez. 1985. A multiple sequence  align- 
ment program.  Nucleic Acids Res. 14:363. 
28.  Ghosh, D. 1990. A relational database of transcription factors. 
Nucleic Acids Res. 18:1749. 
29.  Lai,  E., P. Concannon, and L. Hood. 1988. Conserved organi- 
zation of the human and murine T cell receptor/5 gene fami- 
lies. Nature (Lond.). 331:543. 
30.  Weber, J.L., and P.E. May. 1989. Abundant  class of human 
DNA polymorphisms  which can be typed using the polymerase 
chain reactions. Am. J. Hum.  Genet. 44:388. 
31.  Litt, M., and J.A. Duly. 1989. A hypervariable microsatellite 
revealed  by in vitro amplification  of  a dinucleotide  repeat within 
the cardiac muscle actin gene. Am. J. Hum.  Genet. 44:397. 
32.  Nordheim,  A.,  and  A.  Rich.  1983. The  sequence (dC- 
dA)n.(dG-dT)n  forms left-handed Z-DNA in negatively su- 
percoiled plasmids. Pro~ Natl. Acad. Sci. USA.  80:1821. 
33.  Hamada, H., M.G. Petrino, T. Kakunaga, M. Seidman, and 
B.D.  Stollar. 1984. Characterization  of genomic  Poly(dT- 
dG).Poly(dC-dA) sequences: structure, organization, and con- 
formation.  Mot. Cell. Biol. 4:2610. 
34.  Hamada, H., M. Seidman, B.H. Howard, and C.M. Gorman. 
1984. Enhanced gene expression by the Poly(dT-dG).Poly(dC- 
dA) sequence. Mol. Cell. Biol. 4:2622. 
35.  Nordheim,  A.,  and A.  Rich.  1983. Negatively supercoiled 
simian virus 40 DNA contains Z-DNA segments within tran- 
scriptional enhancer sequences. Nature (Lond.). 303:674. 
36.  Sakano, H., K. Huppi, G. Heinrich, and S. Tonegawa. 1979. 
Sequences at the somatic recombination sites of immunoglob- 
ulin light-chain genes. Nature (Lond.). 280:288. 
37.  Schiffer, M., T.T. Wu, and E.A. Kabat. 1986. Subgroups of 
variable region genes of 15 chains of T-cell receptors for an- 
tigen. Proc. Natl. Acad. Sci. USA.  83:4461. 
38.  Chothia,  C., D.R. Boswell, and A.M. Lesk. 1988. The out- 
line structure  of the T cell c~/B receptor. EMBO (Eur. Mol. 
1546  Structure  of Human VB6 T Cell Antigen Receptor Genes Biol. Organ.)  J.  7:3745. 
39.  Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcrip- 
tion factor AP-1 interacts with TPA-inducible enhancer ele- 
ments.  Cell. 49:741. 
40.  Montminy, M.R., and L.M. Bilezikjian. 1987. Binding of a 
nuclear protein to the cyclic-AMP  response element of the so- 
matostatin  gene. Nature (Land.). 328:175. 
41.  Montminy, M.R., K.A. Sevarino,  J.A. Wagner, G. Mandel, 
and R.H.  Goodman.  1986. Identification of a cyclic-AMP- 
responsive  element within the rat somatostatin gene. Proa Natl. 
Acad. Sci. USA.  83:6682. 
42.  Vogt, P.K., and T.J. Bos. 1989. The oncogenejun and nuclear 
signalling. Trends Biochera. Sci.,  14:172. 
43.  Lee, M.G.-S., C. Loomis, and N.J.  Cowan.  1984. Sequence 
of  an expressed  human 3-tubulin gene containing ten Alu family 
members. Nucleic Acids Res. 12:5823. 
44.  Weiner, A.M., P.L. Deininger, and A. Efstratiadis. 1986. Non- 
viral retroposons: genes, pseudogenes, and transposable ele- 
ments generated by the reverse flow of genetic information. 
Annu. Rev. Biochem. 55:631. 
45. Jelinek, W.R., and C.W. Schmid. 1982. Repetitive sequences 
in eukaryotic DNA and their expression. Annu. Rw, Biochera. 
51:813. 
46.  Ullu, E., and C. Tschudi. 1984. Alu sequences are processed 
7SL KNA genes. Nature (Land.). 312:171. 
47.  Canaani, E., O. Dreazen, A. Klar, G. Rechavi, D. Ram, J.K 
Cohen, and D. Givol. 1983. Activation of the c-mos oncogene 
in a mouse plasmacytoma by insertion of an endogenous in- 
tracisternal A-particle genome. Proa Natl.  Acad. Sci. USA. 
80:7118. 
48.  Hawley, K.G., M.J. Shulman, H. Murialdo, D.M. Gibson, and 
N. Hozumi. 1982. Mutant immunoglobulin genes have repeti- 
tive DNA elements inserted into their intervening sequences. 
Proa Natl.  Acad. Sci. USA.  79:7425. 
49.  Lin, C.S., D.A. Goldthwait, and D. Samols. 1988. Identification 
of Alu  transposition  in  human  lung carcinoma cells. Cell. 
54:153. 
50.  Kazazian, H.H., Jr.,  C. Wong, H. Youssoufian, A.F. Scott, 
D.G. Phillips, and S.E. Antonarakis.  1988. Haemophilia A 
resulting from de novo insertion of L1 sequences represents 
a novel  mechanism for mutation in man. Nature(Xond,~ 332:164. 
51.  Morse, B., P.G. Rotherg, V.J. South, J.M. Spandorfer,  and S.M. 
Astrin.  1988. Insertional mutagenesis of the myc locus by a 
LINE-1 sequence in a human breast carcinoma. Nature (Land.). 
333:87. 
52.  Min Man, Y., H. Delius, and D.P. Leader. 1987. Molecular 
analysis of  elements inserted into mouse ~'-actin  processed  pseu- 
dogenes. Nucleic Acids Res. 15:3291. 
53.  Mager, D.L., and N,L. Goodchild. 1989. Homologous recom- 
bination between the LTRs of a human retrovirus-like element 
causes a 5-kb deletion in two siblings. Am. J. Hum.  Genet. 
45:848. 
54.  Posnett, D.N., C.Y. Wang, and S. Friedman. 1986. Inherited 
polymorphism of the human T cell antigen receptor detected 
by a monoclonal antibody. Pro~ Natl. Acad. Sci. USA. 83:7888. 
55.  Posnett, D.N., A. Gottlieb, J.B. Bussel, S.M. Friedman, N. 
Chiorazzi, Y. Li, P. Szabo, N.R. Farid, and M.A. Robinson. 
1988. T cell antigen receptors in autoimmunity. J. Immunol. 
141:1963. 
56.  Maecker, H.T.,  and  R.  Levy. 1989. Prevalence of antigen 
receptor variants in human T cell lines and tumors.J. Imraunol. 
142:1395. 
57.  Fowlkes, B.J., A.M. Kruisbeek, H. Ton-That, M.A. Weston, 
J.E. Coligan, R.H. Schwartz, and D.M. PardoU. 1987. A novel 
population of T cells receptor orB-bearing thymocytes which 
predominantly express a single VB gene family.  Nature (Land.). 
329:251. 
58.  Leiden,  J.M., and J. L. Strominger. 1986. Generation of  diver- 
sity of the beta chain of the human T-lymphocyte receptor for 
antigen.  Proa Natl.  Acad. Sci. USA.  83:4456. 
1547  Li et al. 